| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,726,000 | 8,957,000 | 8,320,000 | 9,154,000 | | Cost of Revenue | 7,303,000 | 7,530,000 | 6,916,000 | 7,326,000 | | | Gross Profit | 1,423,000 | 1,427,000 | 1,404,000 | 1,828,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 768,000 | 774,000 | 749,000 | 920,000 | | Non Recurring |
-
|
-
|
-
| 3,060,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 655,000 | 653,000 | 655,000 | (2,152,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 41,000 | 13,000 | 8,000 | (34,000) | | Earnings Before Interest And Taxes | 696,000 | 666,000 | 663,000 | (2,186,000) | | Interest Expense | 76,000 | 70,000 | 73,000 | 72,000 | | Income Before Tax | 620,000 | 596,000 | 590,000 | (2,258,000) | | Income Tax Expense | 133,000 | 202,000 | 201,000 | 278,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 487,000 | 394,000 | 389,000 | (2,536,000) | | | Non-recurring Events | | Discontinued Operations | 3,000 |
-
|
-
| 3,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 490,000 | 394,000 | 389,000 | (2,533,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $490,000 | $394,000 | $389,000 | ($2,533,000) |
|
1.52% Nasdaq 
Income Statement
